Latest Articles
Can volume confirm reversal in EPMV - Market Sentiment Review & Long-Term Capital Growth Strategies - Newser
Can volume confirm reversal in EPMV - Market Sentiment Review & Long-Term Capital Growth Strategies Newser
Published: Aug. 15, 2025, 10:05 a.m.
The role of TGF-β superfamily in endometriosis: a systematic review - Frontiers
The role of TGF-β superfamily in endometriosis: a systematic review Frontiers
Published: Aug. 12, 2025, 5:52 a.m.
Multimodal imaging features of high-grade endometrial stromal sarcoma with pulmonary and nodal metastases: A case report and literature review - Frontiers
Multimodal imaging features of high-grade endometrial stromal sarcoma with pulmonary and nodal metastases: A case report and literature review Frontiers
Published: Aug. 11, 2025, 9:32 a.m.
The Efficacy of Acupuncture on Endometrial Receptivity in Infertile Women: An overview of Systematic Review and Meta-Analysis - Frontiers
The Efficacy of Acupuncture on Endometrial Receptivity in Infertile Women: An overview of Systematic Review and Meta-Analysis Frontiers
Published: Aug. 8, 2025, 4:52 p.m.
Low-grade endometrial stromal sarcoma: a case report and literature review - Frontiers
Low-grade endometrial stromal sarcoma: a case report and literature review Frontiers
Published: Aug. 5, 2025, 7:58 a.m.
Review: The Last laugh at Opera House is 'a hilarious peek behind the curtain at three British comedy giants' - I Love Manchester
Review: The Last laugh at Opera House is 'a hilarious peek behind the curtain at three British comedy giants' I Love Manchester
Published: July 30, 2025, 8:47 a.m.
Review: The Last laugh at Opera House is 'a hilarious peek behind the curtain at three British comedy giants' - ilovemanchester.com
Review: The Last laugh at Opera House is 'a hilarious peek behind the curtain at three British comedy giants' ilovemanchester.com
Published: July 30, 2025, 8:47 a.m.
Women's health supplementation enters new era with DITTO and Fairhaven innovations - Nutraceutical Business Review
Women's health supplementation enters new era with DITTO and Fairhaven innovations Nutraceutical Business Review
Published: July 26, 2025, 7:21 a.m.
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms - Contemporary OB/GYN
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms Contemporary OB/GYN
Published: July 25, 2025, 5:43 p.m.
Contemporary OB/GYN week in review: HSDD treatment, PAS guidelines, and more - Contemporary OB/GYN
Contemporary OB/GYN week in review: HSDD treatment, PAS guidelines, and more Contemporary OB/GYN
Published: July 25, 2025, 2:49 p.m.
Link copied to clipboard!